IVF vs AMIX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 16, 2026

IVF

41.6
AI Score
VS
AMIX Wins

AMIX

50.0
AI Score

Investment Advisor Scores

IVF

42score
Recommendation
HOLD

AMIX

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric IVF AMIX Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 16.7% 0.0% IVF
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 41.6/100 50.0/100 AMIX
Profit Margin -92.3% 0.0% AMIX
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

IVF 1M: -47.7% · 3M: -46.7% AMIX 1M: -37.2% · 3M: -14.4%

Current Technical Phase

IVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.0%), weak momentum, RSI 21

RSI (14): 20.7 · Price: $0.53

AMIX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -22.8%), weak momentum, RSI 25

RSI (14): 25.1 · Price: $2.50

Fundamentals Snapshot

Metric IVF AMIX
Market Cap — —
Forward P/E -0.1 -1.5
Trailing P/E 0.0 —
Revenue (TTM) — —
Revenue Growth 0.2% 0.0%
Gross Margin 0.4% —
Operating Margin -0.6% 0.0%
EPS 127.95 -39.22
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AMIX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.